SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-15-091300
Filing Date
2015-03-13
Accepted
2015-03-13 16:39:14
Documents
19
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d824216d10k.htm 10-K 1532007
2 EX-10.55 d824216dex1055.htm EX-10.55 34575
3 EX-10.56 d824216dex1056.htm EX-10.56 261483
4 EX-10.58 d824216dex1058.htm EX-10.58 23354
5 EX-10.59 d824216dex1059.htm EX-10.59 18569
6 EX-10.60 d824216dex1060.htm EX-10.60 24277
7 EX-10.61 d824216dex1061.htm EX-10.61 83852
8 EX-10.62 d824216dex1062.htm EX-10.62 141244
9 EX-23.1 d824216dex231.htm EX-23.1 1513
10 EX-31.1 d824216dex311.htm EX-31.1 8928
11 EX-31.2 d824216dex312.htm EX-31.2 9107
12 EX-32.1 d824216dex321.htm EX-32.1 5137
19 GRAPHIC g824216g52k62.jpg GRAPHIC 89481
  Complete submission text file 0001193125-15-091300.txt   12419078

Data Files

Seq Description Document Type Size
13 XBRL INSTANCE DOCUMENT vnda-20141231.xml EX-101.INS 1679981
14 XBRL TAXONOMY EXTENSION SCHEMA vnda-20141231.xsd EX-101.SCH 91352
15 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vnda-20141231_cal.xml EX-101.CAL 122913
16 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vnda-20141231_def.xml EX-101.DEF 556851
17 XBRL TAXONOMY EXTENSION LABEL LINKBASE vnda-20141231_lab.xml EX-101.LAB 630144
18 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vnda-20141231_pre.xml EX-101.PRE 663205
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34186 | Film No.: 15699849
SIC: 2834 Pharmaceutical Preparations